肿瘤标志物的转化研究进展。
Translational progress on tumor biomarkers.
机构信息
Key Laboratory of Longevity and Aging-Related Diseases, Ministry of Education Nanning, China ; Center for Translational Medicine, Guangxi Medical University Nanning, China.
Department of Urology and Pathology, School of Medicine, University of Michigan Ann Arbor, Michigan, USA.
出版信息
Thorac Cancer. 2015 Nov;6(6):665-71. doi: 10.1111/1759-7714.12294. Epub 2015 Jul 27.
Abstract
There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been addressed in cancer biology, particularly in the identification and characterization of novel tumor biomarkers. This review focuses on the recent achievements and clinical application prospects in tumor biomarkers based on translational medicine.
摘要
迫切需要将基础研究成果应用于临床。具体而言，应当根据临床需求由 bench 研究人员开展机制研究，以提高癌症患者的生存率和生活质量。迄今为止，转化医学已在癌症生物学中得到了研究，特别是在新型肿瘤标志物的鉴定和特征描述方面。本文重点介绍了基于转化医学的肿瘤标志物的最新研究进展和临床应用前景。
相似文献
1
Translational progress on tumor biomarkers.
Thorac Cancer. 2015 Nov;6(6):665-71. doi: 10.1111/1759-7714.12294. Epub 2015 Jul 27.
2
[Development of antituberculous drugs: current status and future prospects].
Kekkaku. 2006 Dec;81(12):753-74.
3
Conquering cancer through discovery research.
IUBMB Life. 2010 Sep;62(9):655-9. doi: 10.1002/iub.369.
4
Prospects for translational regenerative medicine.
Biotechnol Adv. 2012 May-Jun;30(3):658-72. doi: 10.1016/j.biotechadv.2011.11.005. Epub 2011 Nov 27.
5
Translational research: from benchside to bedside.
Injury. 2008 Jun;39(6):643-50. doi: 10.1016/j.injury.2008.01.051. Epub 2008 May 27.
6
Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S67-78. doi: 10.1016/j.ijrobp.2007.04.090.
7
Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
Expert Opin Drug Metab Toxicol. 2016;12(3):253-65. doi: 10.1517/17425255.2016.1141895.
8
Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Proteomics Clin Appl. 2016 Apr;10(4):503-15. doi: 10.1002/prca.201500082. Epub 2016 Feb 3.
9
Translational metabolomics in cancer research.
Biomark Med. 2015;9(9):821-34. doi: 10.2217/bmm.15.52. Epub 2015 Sep 1.
10
[Translational medicine is advocated on the ophthalmic research in China].
Zhonghua Yan Ke Za Zhi. 2011 Mar;47(3):193-5.
引用本文的文献
1
Identification of an autophagy- and macropinocytosis-related prognostic signature for the prediction of prognosis and therapeutic response in gastric cancer.
Genes Genomics. 2024 Oct;46(10):1149-1164. doi: 10.1007/s13258-024-01557-z. Epub 2024 Aug 16.
2
Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review.
Discov Oncol. 2022 Sep 24;13(1):91. doi: 10.1007/s12672-022-00551-9.
3
Surface-enhanced Raman scattering (SERS)-based immunosystem for ultrasensitive detection of the 90K biomarker.
Anal Bioanal Chem. 2020 Nov;412(27):7659-7667. doi: 10.1007/s00216-020-02903-2. Epub 2020 Sep 2.
4
Prognostic value of carbohydrate antigen125 and carcino embryonic antigen expression in patients with colorectal carcinoma and its guiding significance for chemotherapy.
Medicine (Baltimore). 2020 Apr;99(14):e19420. doi: 10.1097/MD.0000000000019420.
5
Comparison of overall survival and quality of life between patients undergoing anal reconstruction and patients undergoing traditional lower abdominal stoma after radical resection.
Clin Transl Oncol. 2019 Oct;21(10):1390-1397. doi: 10.1007/s12094-019-02106-x. Epub 2019 Apr 20.
6
Robust and accurate quantification of biomarkers of immune cells in lung cancer micro-environment using deep convolutional neural networks.
PeerJ. 2019 Apr 10;7:e6335. doi: 10.7717/peerj.6335. eCollection 2019.
7
EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma.
Int J Oncol. 2018 May;52(5):1443-1454. doi: 10.3892/ijo.2018.4316. Epub 2018 Mar 14.
8
Tumour biomarkers: homeostasis as a novel prognostic indicator.
Open Biol. 2016 Dec;6(12). doi: 10.1098/rsob.160254.
9
Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Oncotarget. 2017 Jan 3;8(1):954-966. doi: 10.18632/oncotarget.13512.
10
Predicting Clinical Outcomes Using Molecular Biomarkers.
Biomark Cancer. 2016 Jun 6;8:89-99. doi: 10.4137/BIC.S33380. eCollection 2016.
本文引用的文献
1
Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.
J Clin Microbiol. 2015 Aug;53(8):2509-16. doi: 10.1128/JCM.01013-15. Epub 2015 May 27.
2
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status.
Oncotarget. 2015 Sep 8;6(26):23015-25. doi: 10.18632/oncotarget.4132.
3
Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
Cancer Prev Res (Phila). 2015 Aug;8(8):729-36. doi: 10.1158/1940-6207.CAPR-14-0397. Epub 2015 May 19.
4
Screening of cervical cancer in Catalonia 2006-2012.
Ecancermedicalscience. 2015 Apr 29;9:532. doi: 10.3332/ecancer.2015.532. eCollection 2015.
5
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.
Ecancermedicalscience. 2015 Apr 29;9:528. doi: 10.3332/ecancer.2015.528. eCollection 2015.
6
Russian study of morphological prognostic factors characterization in BRAF-mutant cutaneous melanoma.
Pathol Res Pract. 2015 Jul;211(7):521-7. doi: 10.1016/j.prp.2015.03.005. Epub 2015 Apr 2.
7
Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
Oncotarget. 2015 Apr 20;6(11):9592-9. doi: 10.18632/oncotarget.3562.
8
Elevated serum CA 19-9 level associated with a splenic cyst: which is the actual clinical management? Review of the literature.
Ann Ital Chir. 2015 Jan-Feb;86(1):22-9.
9
Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
PLoS One. 2015 Mar 20;10(3):e0119755. doi: 10.1371/journal.pone.0119755. eCollection 2015.
10
Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
Semin Diagn Pathol. 2015 Sep;32(5):362-9. doi: 10.1053/j.semdp.2015.02.011. Epub 2015 Feb 7.
Zotero 插件